Related Experiment Video
Updated: Aug 11, 2026
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Which phototherapy system is most effective in lowering serum bilirubin in very preterm infants?
Costantino Romagnoli1, Enrico Zecca, Patrizia Papacci
1Division of Neonatology, Catholic University of Rome, Rome, Italy. cromagnoli@rm.unicatt.it
Insights
Combined phototherapy is the most effective treatment for lowering high serum bilirubin levels in very preterm infants. This method significantly reduces treatment duration and the need for exchange transfusions.
Area of Science:
- Neonatal Medicine
- Pediatric Phototherapy Research
- Neonatal Hyperbilirubinemia Management
Background:
- Hyperbilirubinemia is a common condition in preterm infants.
- Effective management is crucial to prevent neurological complications.
- Various phototherapy systems exist, but their comparative efficacy in very preterm infants requires clarification.
Purpose of the Study:
- To compare the effectiveness of different phototherapy systems in reducing serum bilirubin levels in preterm infants.
- To evaluate conventional, fiberoptic (Wallaby, Biliblanket), and combined phototherapy approaches.
Main Methods:
- A randomized clinical trial involving 140 preterm infants (gestational age ≤30 weeks) with nonhemolytic hyperbilirubinemia.
- Infants were assigned to conventional, Wallaby, Biliblanket, or combined phototherapy groups when total serum bilirubin reached 6.0 mg/dl.
- Efficacy was measured by peak bilirubin levels, treatment duration, and exchange transfusion rates.
Main Results:
- Fiberoptic phototherapy (Wallaby and Biliblanket) demonstrated similar effectiveness to conventional phototherapy.
- Combined phototherapy yielded superior results, achieving lower bilirubin levels and shorter treatment durations.
- Combined phototherapy significantly reduced the requirement for exchange transfusions.
Conclusions:
- Combined phototherapy is highly effective in managing hyperbilirubinemia in very preterm infants.
- This approach offers advantages over conventional and standalone fiberoptic methods.
- Combined phototherapy should be considered the preferred treatment strategy.
Objective:
To compare the effectiveness of various phototherapy systems in lowering serum bilirubin levels in preterm infants.
Methods:
This randomized clinical trial enrolled 140 preterm infants with gestational age < or =30 weeks and presenting nonhemolytic hyperbilirubinemia. When total serum bilirubin level reached 6.0 mg/dl (102.6 micromol/l), eligible infants were randomly assigned to four study groups: conventional, fiberoptic Wallaby, fiberoptic Biliblanket, and combined phototherapy. Efficacy was assessed by comparing highest serum bilirubin levels, duration of treatment, and number of infants requiring exchange transfusion.
Results:
Our results confirm that fiberoptic phototherapy, both Wallaby and Biliblanket, had the same effectiveness of conventional phototherapy. The best results have been obtained using combined phototherapy, which allowed to reach lower serum bilirubin levels, a shorter duration of treatment and a significant reduction of exchange transfusions.
Conclusion:
Our data suggest that combined phototherapy should be the method of choice in treating hyperbilirubinemia in very preterm infants.
Related Concept Videos
01:25Jaundice
01:27Acne Infection